TITLE

Adherence Assessment to Highly Active Antiretroviral Therapy

AUTHOR(S)
Tsasis, Peter
PUB. DATE
March 2001
SOURCE
AIDS Patient Care & STDs;Mar2001, Vol. 15 Issue 3, p109
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Adherence to highly active antiretroviral therapy (HAART) is the outcome of a dynamic process of clinical and behavioral interactions. This article reviews factors influencing this process and provides suggestions to enhance adherence to HAART. Interventions to improve adherence to HAART should combine efficacy of treatments with a strong patient-provider alliance and cognitive behavioral interventions.
ACCESSION #
4490622

 

Related Articles

  • SELF-REPORTED ADHERENCE NOT RELIABLE.  // AIDS Patient Care & STDs;Jan1999, Vol. 13 Issue 1, p59 

    Reports that self-reporting of adherence to various anti-retroviral therapies is not a reliable method when used alone. Electronic monitoring of adherence.

  • Adherence of Human Immunodeficiency Virus-Infected Patients to Antiretroviral Therapy. Singh, Nina; Berman, Stephen M.; Swindells, Susan; Justis, Janice C.; Mohr, Jeffrey A.; Squier, Cheryl; Wagener, Marilyn M. // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p824 

    Presents a study which assessed the role of demographic, psychosocial and medical-regimen variables on adherence of HIV-infected patients to antiretroviral therapy. Characteristics of the patients; Data and methods used; Results and discussion.

  • HAART Adherence in Culturally Diverse Patients with HIV/AIDS: A Study of Male Patients from a... Kemppainen, Jeanne K.; Levine, Roger E.; Mistal, Mark; Schmidgall, Donald // AIDS Patient Care & STDs;Mar2001, Vol. 15 Issue 3, p117 

    Identifies the factors influencing adherence to antiretroviral medication regimens in culturally diverse populations with HIV/AIDS related to age, ethnicity and intravenous drug use. Use of the critical incident technique to identify factors determining adherence; Patients most influenced by...

  • Treat HIv-1 Infected with at Least Two Antiretrovirals.  // Kidney;Sep/Oct99, Vol. 8 Issue 5, p203 

    Discusses an abstract of the article, entitled `Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients,' by T.S. Ahuja, N. Niaz. A. Velasco and others.

  • VIRACEPT COMBINATIONS STUDIES.  // AIDS Patient Care & STDs;Jun98, Vol. 12 Issue 6, p495 

    Presents information on the fifth Conference on Retroviruses and Opportunistic Infections in Chicago in 1998. Summarization of the results from clinical trials of the drug Viracept; Use of the drug with other protease inhibitors and anti-human immunodeficiency virus (HIV) drugs; Evaluation of...

  • A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997--1999. Bonnet, F.; Lawson-Ayayi, S.; Thiébaut, R.; Ramanampamonjy, R.; Lacoste, D.; Bernard, N.; Malvy, D.; Bonarek, M.; Djossou, F.; Beylot, J.; Dabis, F.; Morlat, P. // Clinical Infectious Diseases;11/15/2002, Vol. 35 Issue 10, p1231 

    We performed a retrospective study to evaluate, under routine circumstances, the tolerance and immunovirological changes associated with antiretroviral regimens that contain nevirapine in 137 patients (88% were antiretroviral experienced). During a mean follow-up of 11 months, 33% of patients...

  • Stavudine Once Daily. Cheer, S.M.; Goa, K.L. // Drugs;2002, Vol. 62 Issue 18, p2667 

    â–´ Stavudine administered once daily is a nucleoside analogue reverse transcriptase inhibitor. â–´ The efficacy (reduction in viral load and increase in CD4+ lymphocyte counts from baseline) of stavudine once daily-containing triple therapy was similar to that of stavudine immediate...

  • Failure of a prospective trial to detect cytomegalovirus retinitis after initiation of highly... Uphold, Constance R.; Smith, Fran // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p907 

    Determines the incidence of cytomegalovirus (CMV) retinis prior to and after initiation with highly active antiretroviral therapy (HAART). Decrease in viral loads and increase in CD4+ T-cell counts after starting HAART; Non-occurrence of CMV retinis among patients receiving HAART; Development...

  • T-20 SHOWS PROMISE.  // AIDS Patient Care & STDs;Mar1999, Vol. 13 Issue 3, p200 

    Reports on the results of the first multidose human trial of the antiretroviral T-20. Decrease in patients' viral load; Results of similar trials using triple-drug HAART and four-drug HAART.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics